GSA Capital Partners’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Sell |
129,731
-224,826
| -63% | -$709K | 0.03% | 1051 |
|
|
2025
Q1 | $1.11M | Sell |
354,557
-25,513
| -7% | -$80.1K | 0.1% | 296 |
|
|
2024
Q4 | $1.65M | Buy |
380,070
+193,420
| +104% | +$840K | 0.12% | 146 |
|
|
2024
Q3 | $498K | Buy |
186,650
+151,613
| +433% | +$405K | 0.04% | 908 |
|
|
2024
Q2 | $78K | Buy |
+35,037
| New | +$78K | 0.01% | 1546 |
|
|
2023
Q4 | – | Sell |
-25,975
| Closed | -$36K | – | 1553 |
|
|
2023
Q3 | $36K | Sell |
25,975
-270,702
| -91% | -$375K | ﹤0.01% | 1429 |
|
|
2023
Q2 | $436K | Buy |
296,677
+15,998
| +6% | +$23.5K | 0.04% | 826 |
|
|
2023
Q1 | $463K | Sell |
280,679
-71,507
| -20% | -$118K | 0.05% | 767 |
|
|
2022
Q4 | $493K | Buy |
352,186
+234,312
| +199% | +$328K | 0.06% | 609 |
|
|
2022
Q3 | $182K | Buy |
117,874
+579
| +0.5% | +$894 | 0.02% | 1256 |
|
|
2022
Q2 | $258K | Buy |
117,295
+53,546
| +84% | +$118K | 0.04% | 918 |
|
|
2022
Q1 | $158K | Buy |
63,749
+48,237
| +311% | +$120K | 0.02% | 1224 |
|
|
2021
Q4 | $93K | Buy |
+15,512
| New | +$93K | 0.01% | 1316 |
|
|
2021
Q3 | – | Sell |
-24,214
| Closed | -$161K | – | 1489 |
|
|
2021
Q2 | $161K | Buy |
+24,214
| New | +$161K | 0.02% | 1212 |
|
|
2017
Q2 | – | Sell |
-236
| Closed | -$20K | – | 1713 |
|
|
2017
Q1 | $20K | Buy |
+236
| New | +$20K | ﹤0.01% | 1701 |
|
|
2016
Q3 | – | Sell |
-153
| Closed | -$50K | – | 1792 |
|
|
2016
Q2 | $50K | Buy |
+153
| New | +$50K | ﹤0.01% | 1696 |
|